Drug regulator under fire over herbal supplement company’s claims

Therapeutic Goods Administration approved advertising for product said to relieve urologic symptoms, despite scientific evidence to the contrary

The Therapeutic Goods Administration has been accused of putting the supplements industry before consumers after it allowed a herbal remedy manufacturer to advertise one of its products as helpful in relieving urologic symptoms - despite scientific evidence to the contrary.

The TGA approved an application from the Tomato Pill Company requesting permission to advertise a product called Ateronon XY Pro as helpful in relieving the symptoms associated with an enlarged prostate, including weak urine flow and frequent daytime and night-time urination.